A Phase II, single-arm clinical trial of administration of cisplatin and 5-fluorouracil with afatinib as first-line therapy in patients with inoperable gastric or gastroesophageal junction cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 May 2019
At a glance
- Drugs Afatinib (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Carcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms A-GAPP
- 10 May 2019 Planned primary completion date changed from 1 Mar 2019 to 1 May 2019.
- 21 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019.
- 06 Nov 2018 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019.